Sinew Pharma has over 90 patent applications, with 60 already granted. Our new drug patent protection spans more than 30 countries, securing market advantages through a comprehensive global strategic layout. From inhibitor applications to liver metabolic enzyme technology platforms, we employ multi-layered and comprehensive patent protection and strategic positioning to extend protection periods effectively.